Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 489 - 496 of 11616 results
Terminated Sale Of NBA's T-Wolves Looks Like A Power Play
April 23, 2024| News
Empowering Survivors: Spotlight on Mintz’s Pro Bono Champion, Nick Butto
April 23, 2024| News
Mintz Direct
April 22, 2024| Blog| Viewpoint
USPTO Issues Guidance on AI Use to Patent Professionals — AI: The Washington Report
April 22, 2024| Article| Viewpoint
Doing Life Sciences Deals in 2024
April 22, 2024| Blog| Viewpoint
NYC “Know Your Rights” Poster and Bill of Rights Website Now Live
April 22, 2024| Blog| Viewpoint
Canada’s Federal Budget 2024: More Changes to the Stock Option Rules = More Headaches for Employers
April 22, 2024| Alert| Viewpoint
Preparing a VC-Backed Company for an Exit Event
April 22, 2024| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.